1
|
Ménard M, Ali LMA, Vardanyan A, Charnay C, Raehm L, Cunin F, Bessière A, Oliviero E, Theodossiou TA, Seisenbaeva GA, Gary-Bobo M, Durand JO. Upscale Synthesis of Magnetic Mesoporous Silica Nanoparticles and Application to Metal Ion Separation: Nanosafety Evaluation. NANOMATERIALS (BASEL, SWITZERLAND) 2023; 13:3155. [PMID: 38133052 PMCID: PMC10745894 DOI: 10.3390/nano13243155] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Received: 10/20/2023] [Revised: 12/06/2023] [Accepted: 12/12/2023] [Indexed: 12/23/2023]
Abstract
The synthesis of core-shell magnetic mesoporous nanoparticles (MMSNs) through a phase transfer process is usually performed at the 100-250 mg scale. At the gram scale, nanoparticles without cores or with multicore systems are observed. Iron oxide core nanoparticles (IO) were synthesized through a thermal decomposition procedure of α-FeO(OH) in oleic acid. A phase transfer from chloroform to water was then performed in order to wrap the IO nanoparticles with a mesoporous silica shell through the sol-gel procedure. MMSNs were then functionalized with DTPA (diethylenetriaminepentacetic acid) and used for the separation of metal ions. Their toxicity was evaluated. The phase transfer procedure was crucial to obtaining MMSNs on a large scale. Three synthesis parameters were rigorously controlled: temperature, time and glassware. The homogeneous dispersion of MMSNs on the gram scale was successfully obtained. After functionalization with DTPA, the MMSN-DTPAs were shown to have a strong affinity for Ni ions. Furthermore, toxicity was evaluated in cells, zebrafish and seahorse cell metabolic assays, and the nanoparticles were found to be nontoxic. We developed a method of preparing MMSNs at the gram scale. After functionalization with DTPA, the nanoparticles were efficient in metal ion removal and separation; furthermore, no toxicity was noticed up to 125 µg mL-1 in zebrafish.
Collapse
Affiliation(s)
- Mathilde Ménard
- ICGM, Univ Montpellier, CNRS, ENSCM, 34193 Montpellier, France; (M.M.); (C.C.); (L.R.); (F.C.); (A.B.); (E.O.)
| | - Lamiaa M. A. Ali
- IBMM, Univ Montpellier, CNRS, ENSCM, 34193 Montpellier, France; (L.M.A.A.); (M.G.-B.)
- Department of Biochemistry, Medical Research Institute, University of Alexandria, Alexandria 21561, Egypt
| | - Ani Vardanyan
- Department of Molecular Sciences, Swedish University of Agricultural Sciences, 750 07 Uppsala, Sweden; (A.V.); (G.A.S.)
| | - Clarence Charnay
- ICGM, Univ Montpellier, CNRS, ENSCM, 34193 Montpellier, France; (M.M.); (C.C.); (L.R.); (F.C.); (A.B.); (E.O.)
| | - Laurence Raehm
- ICGM, Univ Montpellier, CNRS, ENSCM, 34193 Montpellier, France; (M.M.); (C.C.); (L.R.); (F.C.); (A.B.); (E.O.)
| | - Frédérique Cunin
- ICGM, Univ Montpellier, CNRS, ENSCM, 34193 Montpellier, France; (M.M.); (C.C.); (L.R.); (F.C.); (A.B.); (E.O.)
| | - Aurélie Bessière
- ICGM, Univ Montpellier, CNRS, ENSCM, 34193 Montpellier, France; (M.M.); (C.C.); (L.R.); (F.C.); (A.B.); (E.O.)
| | - Erwan Oliviero
- ICGM, Univ Montpellier, CNRS, ENSCM, 34193 Montpellier, France; (M.M.); (C.C.); (L.R.); (F.C.); (A.B.); (E.O.)
| | - Theodossis A. Theodossiou
- Department of Radiation Biology, Institute for Cancer Research, Radium Hospital, Oslo University Hospital, Montebello, 0379 Oslo, Norway;
| | - Gulaim A. Seisenbaeva
- Department of Molecular Sciences, Swedish University of Agricultural Sciences, 750 07 Uppsala, Sweden; (A.V.); (G.A.S.)
| | - Magali Gary-Bobo
- IBMM, Univ Montpellier, CNRS, ENSCM, 34193 Montpellier, France; (L.M.A.A.); (M.G.-B.)
| | - Jean-Olivier Durand
- ICGM, Univ Montpellier, CNRS, ENSCM, 34193 Montpellier, France; (M.M.); (C.C.); (L.R.); (F.C.); (A.B.); (E.O.)
| |
Collapse
|
2
|
Adam A, Mertz D. Iron Oxide@Mesoporous Silica Core-Shell Nanoparticles as Multimodal Platforms for Magnetic Resonance Imaging, Magnetic Hyperthermia, Near-Infrared Light Photothermia, and Drug Delivery. NANOMATERIALS (BASEL, SWITZERLAND) 2023; 13:1342. [PMID: 37110927 PMCID: PMC10145772 DOI: 10.3390/nano13081342] [Citation(s) in RCA: 6] [Impact Index Per Article: 6.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Subscribe] [Scholar Register] [Received: 03/08/2023] [Revised: 03/31/2023] [Accepted: 04/02/2023] [Indexed: 06/19/2023]
Abstract
The design of core-shell nanocomposites composed of an iron oxide core and a silica shell offers promising applications in the nanomedicine field, especially for developing efficient theranostic systems which may be useful for cancer treatments. This review article addresses the different ways to build iron oxide@silica core-shell nanoparticles and it reviews their properties and developments for hyperthermia therapies (magnetically or light-induced), combined with drug delivery and MRI imaging. It also highlights the various challenges encountered, such as the issues associated with in vivo injection in terms of NP-cell interactions or the control of the heat dissipation from the core of the NP to the external environment at the macro or nanoscale.
Collapse
|
3
|
Zhang W, Lv Z, Zhang Y, Gopinath SCB, Yuan Y, Huang D, Miao L. Targeted Diagnosis, Therapeutic Monitoring, and Assessment of Atherosclerosis Based on Mesoporous Silica Nanoparticles Coated with cRGD-Platelets. OXIDATIVE MEDICINE AND CELLULAR LONGEVITY 2022; 2022:6006601. [PMID: 36211824 PMCID: PMC9537012 DOI: 10.1155/2022/6006601] [Citation(s) in RCA: 4] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 05/05/2022] [Accepted: 08/20/2022] [Indexed: 12/07/2022]
Abstract
Objective The off-target effects and severe side effects of PPARα and LXRα agonists greatly limit their application in atherosclerosis (AS). Therefore, this study intended to use mesoporous silica nanoparticles as carriers to generate MnO nanoparticles in situ with T1WI-MRI in mesoporous pores and simultaneously load PPARα and LXRα agonists. Afterward, cRGD-chelated platelet membranes can be used for coating to construct a new nanotheranostic agent. Methods cRGD-platelet@MnO/MSN@PPARα/LXRα nanoparticles were synthesized by a chemical method. Dynamic light scattering (DLS) was utilized to detect the size distribution and polydispersity index (PDI) of the nanoparticles. The safety of the nanoparticles was detected by CCK8 in vitro and HE staining and kidney function in vivo. Cell apoptosis was detected by flow cytometry detection and TUNEL staining. Oxidative stress responses (ROS, SOD, MDA, and NOX levels) were tested via a DCFH-DA assay and commercial kits. Immunofluorescence and phagocytosis experiments were used to detect the targeting of nanoparticles. Magnetic resonance imaging (MRI) was used to detect the imaging performance of cRGD-platelet@MnO/MSN@PPARα/LXRα nanoparticles. Using western blotting, the expression changes in LXRα and ABCA1 were identified. Results cRGD-platelet@MnO/MSN@PPARα/LXRα nanoparticles were successfully established, with a particle size of approximately 150 nm and PDI less than 0.3, and showed high safety both in vitro and in vivo. cRGD-platelet@MnO/MSN@PPARα/LXRα nanoparticles showed good targeting properties and better MRI imaging performance in AS. cRGD-platelet@MnO/MSN@PPARα/LXRα nanoparticles showed better antioxidative capacities, MRI imaging performance, and diagnostic and therapeutic effects on AS by regulating the expression of LXRα and ABCA1. Conclusion In the present study, cRGD-platelet@MnO/MSN@PPARα/LXRα nanoparticles with high safety and the capacity to target vulnerable plaques of AS were successfully established. They showed better performance on MRI images and treatment effects on AS by promoting cholesterol efflux through the regulation of ABCA1. These findings might address the problems of off-target effects and side effects of nanoparticle-mediated drug delivery, which will enhance the efficiency of AS treatment and provide new ideas for the clinical treatment of AS.
Collapse
Affiliation(s)
- Wei Zhang
- Department of Radiology, Liuzhou People's Hospital Affiliated to Guangxi Medical University, Liuzhou, Guangxi 545006, China
| | - Zheng Lv
- Department of Radiology, Affiliated Hospital of Guilin Medical University, Guilin, Guangxi 541001, China
| | - Yupeng Zhang
- Department of Radiology, Affiliated Hospital of Guilin Medical University, Guilin, Guangxi 541001, China
| | - Subash C. B. Gopinath
- Faculty of Chemical Engineering & Technology, Micro System Technology, Centre of Excellence (CoE), and Institute of Nano Electronic Engineering, Universiti Malaysia Perlis (UniMAP), Perlis, Malaysia
| | - Yi Yuan
- Institute of Life Sciences, Jiangsu University, Zhengjiang, Jiangsu 212013, China
| | - Deyou Huang
- Department of Radiology, The Affiliated Hospital of Youjiang Medical University for Nationalities, Baise, Guangxi 533000, China
| | - Liu Miao
- Department of Cardiology, Liuzhou People's Hospital Affiliated to Guangxi Medical University, Liuzhou, Guangxi 545006, China
| |
Collapse
|
4
|
Thangudu S, Huang EY, Su CH. Safe magnetic resonance imaging on biocompatible nanoformulations. Biomater Sci 2022; 10:5032-5053. [PMID: 35858468 DOI: 10.1039/d2bm00692h] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/22/2022]
Abstract
Magnetic resonance imaging (MRI) holds promise for the early clinical diagnosis of various diseases, but most clinical MR techniques require the use of a contrast medium. Several nanomaterial (NM) mediated contrast agents (CAs) are widely used as T1- and T2-based MR contrast agents for clinical and non-clinical applications. Unfortunately, most NM-based CAs are toxic or non-biocompatible, restricting their practical/clinical applications. Therefore, the development of nontoxic and biocompatible CAs for clinical MRI diagnosis is highly desired. To this end, several biocompatible and biomimetic strategies have been developed to offer long blood circulation time, significant biocompatibility, in vivo biodistribution and high contrast ability for efficient imaging. However, detailed review reports on biocompatible NMs, specifically for MR imaging have not yet been summarized. Thus, in the present review we summarize various surface coating strategies (such as polymers, proteins, cell membranes, etc.) to achieve biocompatible NPs, providing a detailed discussion of advances and future prospects for safe MRI imaging.
Collapse
Affiliation(s)
- Suresh Thangudu
- Institute for Translational Research in Biomedicine, Kaohsiung Chang Gung Memorial Hospital, Kaohsiung 833, Taiwan.
| | - Eng-Yen Huang
- Department of Radiation Oncology, Chang Gung Memorial Hospital, Kaohsiung, Taiwan
| | - Chia-Hao Su
- Institute for Translational Research in Biomedicine, Kaohsiung Chang Gung Memorial Hospital, Kaohsiung 833, Taiwan. .,Center for General Education, Chang Gung University, Taoyuan, 333, Taiwan.,Department of Biomedical Imaging and Radiological Sciences, National Yang Ming Chiao Tung University, Taipei 112, Taiwan
| |
Collapse
|
5
|
Adam A, Harlepp S, Ghilini F, Cotin G, Freis B, Goetz J, Bégin S, Tasso M, Mertz D. Core-shell iron oxide@stellate mesoporous silica for combined near-infrared photothermia and drug delivery: Influence of pH and surface chemistry. Colloids Surf A Physicochem Eng Asp 2022. [DOI: 10.1016/j.colsurfa.2022.128407] [Citation(s) in RCA: 4] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/21/2022]
|
6
|
Korolev D, Postnov V, Aleksandrov I, Murin I. The Combination of Solid-State Chemistry and Medicinal Chemistry as the Basis for the Synthesis of Theranostics Platforms. Biomolecules 2021; 11:1544. [PMID: 34680176 PMCID: PMC8534059 DOI: 10.3390/biom11101544] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/14/2021] [Revised: 10/12/2021] [Accepted: 10/16/2021] [Indexed: 12/15/2022] Open
Abstract
This review presents the main patterns of synthesis for theranostics platforms. We examine various approaches to the interpretation of theranostics, statistics of publications drawn from the PubMed database, and the solid-state and medicinal chemistry methods used for the formation of nanotheranostic objects. We highlight and analyze chemical methods for the modification of nanoparticles, synthesis of spacers with functional end-groups, and the immobilization of medicinal substances and fluorophores. An overview of the modern solutions applied in various fields of medicine is provided, along with an outline of specific examples and an analysis of modern trends and development areas of theranostics as a part of personalized medicine.
Collapse
Affiliation(s)
- Dmitry Korolev
- Almazov National Medical Research Centre, Institute of Experimental Medicine, 2 Akkuratova Str., 197341 Saint Petersburg, Russia; (D.K.); (V.P.)
| | - Viktor Postnov
- Almazov National Medical Research Centre, Institute of Experimental Medicine, 2 Akkuratova Str., 197341 Saint Petersburg, Russia; (D.K.); (V.P.)
- Institute of Chemistry, Saint Petersburg State University, 7/9 Universitetskaya Emb., 199034 Saint Petersburg, Russia;
| | - Ilia Aleksandrov
- Almazov National Medical Research Centre, Institute of Experimental Medicine, 2 Akkuratova Str., 197341 Saint Petersburg, Russia; (D.K.); (V.P.)
| | - Igor Murin
- Institute of Chemistry, Saint Petersburg State University, 7/9 Universitetskaya Emb., 199034 Saint Petersburg, Russia;
| |
Collapse
|
7
|
Mourdikoudis S, Kostopoulou A, LaGrow AP. Magnetic Nanoparticle Composites: Synergistic Effects and Applications. ADVANCED SCIENCE (WEINHEIM, BADEN-WURTTEMBERG, GERMANY) 2021; 8:2004951. [PMID: 34194936 PMCID: PMC8224446 DOI: 10.1002/advs.202004951] [Citation(s) in RCA: 32] [Impact Index Per Article: 10.7] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 12/22/2020] [Indexed: 05/17/2023]
Abstract
Composite materials are made from two or more constituent materials with distinct physical or chemical properties that, when combined, produce a material with characteristics which are at least to some degree different from its individual components. Nanocomposite materials are composed of different materials of which at least one has nanoscale dimensions. Common types of nanocomposites consist of a combination of two different elements, with a nanoparticle that is linked to, or surrounded by, another organic or inorganic material, for example in a core-shell or heterostructure configuration. A general family of nanoparticle composites concerns the coating of a nanoscale material by a polymer, SiO2 or carbon. Other materials, such as graphene or graphene oxide (GO), are used as supports forming composites when nanoscale materials are deposited onto them. In this Review we focus on magnetic nanocomposites, describing their synthetic methods, physical properties and applications. Several types of nanocomposites are presented, according to their composition, morphology or surface functionalization. Their applications are largely due to the synergistic effects that appear thanks to the co-existence of two different materials and to their interface, resulting in properties often better than those of their single-phase components. Applications discussed concern magnetically separable catalysts, water treatment, diagnostics-sensing and biomedicine.
Collapse
Affiliation(s)
- Stefanos Mourdikoudis
- Biophysics GroupDepartment of Physics and AstronomyUniversity College LondonLondonWC1E 6BTUK
- UCL Healthcare Biomagnetic and Nanomaterials Laboratories21 Albemarle StreetLondonW1S 4BSUK
| | - Athanasia Kostopoulou
- Institute of Electronic Structure and Laser (IESL)Foundation for Research and Technology‐Hellas (FORTH)100 Nikolaou PlastiraHeraklionCrete70013Greece
| | - Alec P. LaGrow
- International Iberian Nanotechnology LaboratoryBraga4715‐330Portugal
| |
Collapse
|
8
|
Adam A, Parkhomenko K, Duenas-Ramirez P, Nadal C, Cotin G, Zorn PE, Choquet P, Bégin-Colin S, Mertz D. Orienting the Pore Morphology of Core-Shell Magnetic Mesoporous Silica with the Sol-Gel Temperature. Influence on MRI and Magnetic Hyperthermia Properties. Molecules 2021; 26:molecules26040971. [PMID: 33673084 PMCID: PMC7917716 DOI: 10.3390/molecules26040971] [Citation(s) in RCA: 7] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/29/2020] [Revised: 01/29/2021] [Accepted: 02/07/2021] [Indexed: 11/17/2022] Open
Abstract
The controlled design of robust, well reproducible, and functional nanomaterials made according to simple processes is of key importance to envision future applications. In the field of porous materials, tuning nanoparticle features such as specific area, pore size and morphology by adjusting simple parameters such as pH, temperature or solvent is highly needed. In this work, we address the tunable control of the pore morphology of mesoporous silica (MS) nanoparticles (NPs) with the sol-gel reaction temperature (Tsg). We show that the pore morphology of MS NPs alone or of MS shell covering iron oxide nanoparticles (IO NPs) can be easily tailored with Tsg orienting either towards stellar (ST) morphology (large radial pore of around 10 nm) below 80 °C or towards a worm-like (WL) morphology (small randomly oriented pores channel network, of 3–4 nm pore size) above 80 °C. The relaxometric and magnetothermal features of IO@STMS or IO@WLMS core shell NPs having respectively stellar or worm-like morphologies are compared and discussed to understand the role of the pore structure for MRI and magnetic hyperthermia applications.
Collapse
Affiliation(s)
- Alexandre Adam
- Institut de Physique et Chimie des Matériaux de Strasbourg (IPCMS), UMR-7504 CNRS-Université de Strasbourg, 23 rue du Lœss, 67034 Strasbourg, France; (A.A.); (P.D.-R.); (C.N.); (G.C.); (S.B.-C.)
| | - Ksenia Parkhomenko
- Institut de Chimie et Procédés pour l’Energie, l’Environnement et la Santé (ICPEES), UMR-7515 CNRS-Université de Strasbourg, 25 rue Becquerel, 67087 Strasbourg, France;
| | - Paula Duenas-Ramirez
- Institut de Physique et Chimie des Matériaux de Strasbourg (IPCMS), UMR-7504 CNRS-Université de Strasbourg, 23 rue du Lœss, 67034 Strasbourg, France; (A.A.); (P.D.-R.); (C.N.); (G.C.); (S.B.-C.)
| | - Clémence Nadal
- Institut de Physique et Chimie des Matériaux de Strasbourg (IPCMS), UMR-7504 CNRS-Université de Strasbourg, 23 rue du Lœss, 67034 Strasbourg, France; (A.A.); (P.D.-R.); (C.N.); (G.C.); (S.B.-C.)
| | - Geoffrey Cotin
- Institut de Physique et Chimie des Matériaux de Strasbourg (IPCMS), UMR-7504 CNRS-Université de Strasbourg, 23 rue du Lœss, 67034 Strasbourg, France; (A.A.); (P.D.-R.); (C.N.); (G.C.); (S.B.-C.)
| | - Pierre-Emmanuel Zorn
- Imagerie Préclinique—UF6237, Pôle d’imagerie, Hôpitaux Universitaires de Strasbourg, 67000 Strasbourg, France; (P.-E.Z.); (P.C.)
- Service de Radiologie 2, Hautepierre, Pôle d’imagerie, Hôpitaux Universitaires de Strasbourg, 67000 Strasbourg, France
| | - Philippe Choquet
- Imagerie Préclinique—UF6237, Pôle d’imagerie, Hôpitaux Universitaires de Strasbourg, 67000 Strasbourg, France; (P.-E.Z.); (P.C.)
- Service de Radiologie 2, Hautepierre, Pôle d’imagerie, Hôpitaux Universitaires de Strasbourg, 67000 Strasbourg, France
- Icube, équipe MMB, CNRS, Université de Strasbourg, 67000 Strasbourg, France
- Fédération de Médecine Translationnelle de Strasbourg, Faculté de Médecine, Université de Strasbourg, 67000 Strasbourg, France
| | - Sylvie Bégin-Colin
- Institut de Physique et Chimie des Matériaux de Strasbourg (IPCMS), UMR-7504 CNRS-Université de Strasbourg, 23 rue du Lœss, 67034 Strasbourg, France; (A.A.); (P.D.-R.); (C.N.); (G.C.); (S.B.-C.)
| | - Damien Mertz
- Institut de Physique et Chimie des Matériaux de Strasbourg (IPCMS), UMR-7504 CNRS-Université de Strasbourg, 23 rue du Lœss, 67034 Strasbourg, France; (A.A.); (P.D.-R.); (C.N.); (G.C.); (S.B.-C.)
- Correspondence: ; Tel.: +33-88107192
| |
Collapse
|
9
|
Asgari M, Miri T, Soleymani M, Barati A. A novel method for in situ encapsulation of curcumin in magnetite-silica core-shell nanocomposites: A multifunctional platform for controlled drug delivery and magnetic hyperthermia therapy. J Mol Liq 2021. [DOI: 10.1016/j.molliq.2020.114731] [Citation(s) in RCA: 15] [Impact Index Per Article: 5.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
10
|
Bizeau J, Mertz D. Design and applications of protein delivery systems in nanomedicine and tissue engineering. Adv Colloid Interface Sci 2021; 287:102334. [PMID: 33341459 DOI: 10.1016/j.cis.2020.102334] [Citation(s) in RCA: 17] [Impact Index Per Article: 5.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/24/2020] [Revised: 11/24/2020] [Accepted: 11/26/2020] [Indexed: 02/06/2023]
Abstract
Proteins are biological macromolecules involved in a wide range of biological functions, which makes them very appealing as therapeutics agents. Indeed, compared to small molecule drugs, their endogenous nature ensures their biocompatibility and biodegradability, they can be used in a large range of applications and present a higher specificity and activity. However, they suffer from unfolding, enzymatic degradation, short half-life and poor membrane permeability. To overcome such drawbacks, the development of protein delivery systems to protect, carry and deliver them in a controlled way have emerged importantly these last years. In this review, the formulation of a wide panel of protein delivery systems either in the form of polymer or inorganic nanoengineered colloids and scaffolds are presented and the protein loading and release mechanisms are addressed. A section is also dedicated to the detection of proteins and the characterization methods of their release. Then, the main protein delivery systems developed these last three years for anticancer, tissue engineering or diabetes applications are presented, as well as the major in vivo models used to test them. The last part of this review aims at presenting the perspectives of the field such as the use of protein-rich material or the sequestration of proteins. This part will also deal with less common applications and gene therapy as an indirect method to deliver protein.
Collapse
|
11
|
Yuan D, Ellis CM, Davis JJ. Mesoporous Silica Nanoparticles in Bioimaging. MATERIALS (BASEL, SWITZERLAND) 2020; 13:E3795. [PMID: 32867401 PMCID: PMC7504327 DOI: 10.3390/ma13173795] [Citation(s) in RCA: 21] [Impact Index Per Article: 5.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 07/20/2020] [Revised: 08/24/2020] [Accepted: 08/25/2020] [Indexed: 02/07/2023]
Abstract
A biomedical contrast agent serves to enhance the visualisation of a specific (potentially targeted) physiological region. In recent years, mesoporous silica nanoparticles (MSNs) have developed as a flexible imaging platform of tuneable size/morphology, abundant surface chemistry, biocompatibility and otherwise useful physiochemical properties. This review discusses MSN structural types and synthetic strategies, as well as methods for surface functionalisation. Recent applications in biomedical imaging are then discussed, with a specific emphasis on magnetic resonance and optical modes together with utility in multimodal imaging.
Collapse
Affiliation(s)
| | | | - Jason J. Davis
- Department of Chemistry, University of Oxford, South Parks Road, Oxford OX1 3QZ, UK; (D.Y.); (C.M.E.)
| |
Collapse
|
12
|
Tao Y, Wang J, Xu X. Emerging and Innovative Theranostic Approaches for Mesoporous Silica Nanoparticles in Hepatocellular Carcinoma: Current Status and Advances. Front Bioeng Biotechnol 2020; 8:184. [PMID: 32211399 PMCID: PMC7075945 DOI: 10.3389/fbioe.2020.00184] [Citation(s) in RCA: 12] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/15/2019] [Accepted: 02/25/2020] [Indexed: 12/23/2022] Open
Abstract
Hepatocellular carcinoma (HCC) is one of the most prevalent and lethal solid cancers globally. To improve diagnosis sensitivities and treatment efficacies, the development of new theranostic nanoplatforms for efficient HCC management is urgently needed. In the past decade, mesoporous silica nanoparticles (MSNs) with tailored structure, large surface area, high agents loading volume, abundant chemistry functionality, acceptable biocompatibility have received more and more attention in HCC theranostic. This review outlines the recent advances in MSNs-based systems for HCC therapy and diagnosis. The multifunctional hybrid nanostructures that have both of therapy and diagnosis abilities are highlighted. And the precision delivery strategies of MSNs in HCC are also discussed. Final, we conclude with our personal perspectives on the future development and challenges of MSNs.
Collapse
Affiliation(s)
- Yaoye Tao
- Division of Hepatobiliary and Pancreatic Surgery, Department of Surgery First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China
- National Health Commission (NHC) Key Laboratory of Combined Multi-Organ Transplantation, Hangzhou, China
- Key Laboratory of the Diagnosis and Treatment of Organ Transplantation, Chinese Academy of Medical Sciences (CAMS), Hangzhou, China
- Key Laboratory of Organ Transplantation, Hangzhou, China
| | - Jianguo Wang
- Division of Hepatobiliary and Pancreatic Surgery, Department of Surgery First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China
- National Health Commission (NHC) Key Laboratory of Combined Multi-Organ Transplantation, Hangzhou, China
- Key Laboratory of the Diagnosis and Treatment of Organ Transplantation, Chinese Academy of Medical Sciences (CAMS), Hangzhou, China
- Key Laboratory of Organ Transplantation, Hangzhou, China
| | - Xiao Xu
- Division of Hepatobiliary and Pancreatic Surgery, Department of Surgery First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China
- National Health Commission (NHC) Key Laboratory of Combined Multi-Organ Transplantation, Hangzhou, China
- Key Laboratory of the Diagnosis and Treatment of Organ Transplantation, Chinese Academy of Medical Sciences (CAMS), Hangzhou, China
- Key Laboratory of Organ Transplantation, Hangzhou, China
| |
Collapse
|
13
|
Wang X, Lu P, Zhu L, Qin L, Zhu Y, Yan G, Duan S, Guo Y. Anti-CD133 Antibody-Targeted Therapeutic Immunomagnetic Albumin Microbeads Loaded with Vincristine-Assisted to Enhance Anti-Glioblastoma Treatment. Mol Pharm 2019; 16:4582-4593. [PMID: 31573817 DOI: 10.1021/acs.molpharmaceut.9b00704] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
Abstract
Poor uptake of antitumor drugs by tumor cells is a critical challenge for anticancer therapeutics. Moreover, the deficiency of specific tumor selectivity for tumor sites may further limit the therapeutic efficacy and cause side effects in healthy regions of the body. Vincristine (VCR) is an effective antitumor drug; however, because of its severe nerve toxicity, short half-life, and fast metabolism, its clinical application is limited. Herein, novel anti-CD133 monoclonal antibody (CD133mAb)-targeted therapeutic immunomagnetic albumin microbeads (CD133mAb/TMAMbs) are smartly constructed for enhancing antiglioblastoma treatment. Superparamagnetic iron oxide nanoparticles (SPIO NPs) were first fabricated as nanocarrier cores, then encapsulated with human serum albumin (HSA), and loaded antitumor drug VCR. Then CD133mAb, which has specific affinity with the cell membrane CD133, was subsequently conjugated to form CD133mAb-decorated therapeutic immunomagnetic albumin microbeads (CD133mAb/TMAMbs). The influence of CD133mAb/TMAMbs on the viability, cell cycle, apoptosis, cell cytoskeleton, migration, and invasion of CD133-overexpressing U251 cells was explored. The CD133mAb-conjugated magnetic albumin microbeads exhibited a high drug loading capacity, stability and hemocompatibility, and active targeting ability by specific recognition of the CD133 surface antigen by the bioconjugation of CD133mAb. More importantly, the constructed therapeutic CD133mAb/TMAMbs have a specifically effective uptake via the CD133 transmembrane protein that is overexpressed in U251 glioblastoma cells and displayed an effective antitumor proliferation and invasive ability. Therefore, based on these results, the fabricated CD133mAb/TMAMbs demonstrate promising uses in brain cancer-targeted diagnosis and therapy.
Collapse
Affiliation(s)
- Xueqin Wang
- Henan Provincial People's Hospital , Zhengzhou , Henan 450003 , People's Republic of China.,College of Bioengineering , Henan University of Technology , Zhengzhou , Henan 450001 , People's Republic of China
| | - Ping Lu
- Henan Province Direct Third People's Hospital . Zhengzhou , Henan 450003 , People's Republic of China
| | - Li Zhu
- Henan Provincial People's Hospital , Zhengzhou , Henan 450003 , People's Republic of China.,Department of Obstetrics and Gynecology , People's Hospital of Zhengzhou University , Zhengzhou , Henan 450003 , People's Republic of China
| | - Li Qin
- Henan Provincial People's Hospital , Zhengzhou , Henan 450003 , People's Republic of China.,Department of Obstetrics and Gynecology , People's Hospital of Zhengzhou University , Zhengzhou , Henan 450003 , People's Republic of China
| | - Yongxia Zhu
- Henan Provincial People's Hospital , Zhengzhou , Henan 450003 , People's Republic of China.,School of Clinical Medicine , Henan University , Zhengzhou , Henan 450003 , People's Republic of China
| | - Guoyi Yan
- Henan Provincial People's Hospital , Zhengzhou , Henan 450003 , People's Republic of China.,School of Clinical Medicine , Henan University , Zhengzhou , Henan 450003 , People's Republic of China
| | - Shaofeng Duan
- School of Pharmacy , Henan University , Kaifeng , Henan 475004 , People's Republic of China.,Center for Multi-Omics Research, State Key Laboratory of Cotton Biology, Department of Biology, Institute of Plant Stress Biology , Henan University , Kaifeng , Henan 475001 , People's Republic of China
| | - Yuqi Guo
- Henan Provincial People's Hospital , Zhengzhou , Henan 450003 , People's Republic of China.,School of Clinical Medicine , Henan University , Zhengzhou , Henan 450003 , People's Republic of China.,Department of Obstetrics and Gynecology , People's Hospital of Zhengzhou University , Zhengzhou , Henan 450003 , People's Republic of China.,International Joint Laboratory for Gynecological Oncology Nanomedicine of Henan Province , Zhengzhou , Henan 450003 , People's Republic of China
| |
Collapse
|